193 related articles for article (PubMed ID: 18081539)
21. The current burden of Japanese encephalitis and the estimated impacts of vaccination: Combining estimates of the spatial distribution and transmission intensity of a zoonotic pathogen.
Moore SM
PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009385. PubMed ID: 34644296
[TBL] [Abstract][Full Text] [Related]
22. Product review on the JE vaccine IXIARO.
Firbas C; Jilma B
Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
[TBL] [Abstract][Full Text] [Related]
23. IC51 Japanese encephalitis vaccine.
Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
[TBL] [Abstract][Full Text] [Related]
24. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
[TBL] [Abstract][Full Text] [Related]
25. Partial cross-protection between Japanese encephalitis virus genotype I and III in mice.
Wei J; Wang X; Zhang J; Guo S; Pang L; Shi K; Liu K; Shao D; Qiu Y; Liu L; Widén F; Li B; Ma Z
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007601. PubMed ID: 31374086
[TBL] [Abstract][Full Text] [Related]
26. Allergic reactions to Japanese encephalitis vaccine.
Plesner AM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386
[TBL] [Abstract][Full Text] [Related]
27. An intranasal challenge model for testing Japanese encephalitis vaccines in rhesus monkeys.
Raengsakulrach B; Nisalak A; Gettayacamin M; Thirawuth V; Young GD; Myint KS; Ferguson LM; Hoke CH; Innis BL; Vaughn DW
Am J Trop Med Hyg; 1999 Mar; 60(3):329-37. PubMed ID: 10466957
[TBL] [Abstract][Full Text] [Related]
28. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
Srivastava AK; Putnak JR; Lee SH; Hong SP; Moon SB; Barvir DA; Zhao B; Olson RA; Kim SO; Yoo WD; Towle AC; Vaughn DW; Innis BL; Eckels KH
Vaccine; 2001 Aug; 19(31):4557-65. PubMed ID: 11483284
[TBL] [Abstract][Full Text] [Related]
29. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region.
Dubischar KL; Kadlecek V; Sablan JB; Borja-Tabora CF; Gatchalian S; Eder-Lingelbach S; Kiermayr S; Spruth M; Westritschnig K
Pediatr Infect Dis J; 2017 Sep; 36(9):898-904. PubMed ID: 28430748
[TBL] [Abstract][Full Text] [Related]
31. [Tissue culture inactivated vaccine for the prevention of Japanese encephalitis: experimental and laboratory process and control layout].
Loginova IV; Deriabin PG; Tikhomirov EE; Karpova EF
Vopr Virusol; 2007; 52(3):26-9. PubMed ID: 17601048
[TBL] [Abstract][Full Text] [Related]
32. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
Yang SE; Pan MJ; Tseng HF; Liau MY
Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
[TBL] [Abstract][Full Text] [Related]
34. Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control.
Murhekar MV; Oak C; Ranjan P; Kanagasabai K; Shinde S; Pandey AK; Mittal M; Gore M; Mehendale SM
Indian J Med Res; 2017 Jan; 145(1):63-69. PubMed ID: 28574016
[TBL] [Abstract][Full Text] [Related]
35. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
36. Enhancing the utility of a prM/E-expressing chimeric vaccine for Japanese encephalitis by addition of the JEV NS1 gene.
Ishikawa T; Wang G; Widman DG; Infante E; Winkelmann ER; Bourne N; Mason PW
Vaccine; 2011 Oct; 29(43):7444-55. PubMed ID: 21798299
[TBL] [Abstract][Full Text] [Related]
37. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
38. Construction and Immunogenicity of Recombinant Vaccinia Virus Vaccine Against Japanese Encephalitis and Chikungunya Viruses Infection in Mice.
Zhang Y; Han JC; Jing J; Liu H; Zhang H; Li ZH; Jin NY; Lu HJ
Vector Borne Zoonotic Dis; 2020 Oct; 20(10):788-796. PubMed ID: 32584657
[TBL] [Abstract][Full Text] [Related]
39. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M; Lindsey N; Staples JE; Hills S;
MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
[TBL] [Abstract][Full Text] [Related]
40. [The progress and challenge of Japanese encephalitis control and prevention in China].
Wang HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):133-135. PubMed ID: 30744284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]